Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
Aromatic L-amino acid decarboxylase deficiency (AADC) is a rare neurodevelopmental disorder. Here the authors describe a clinical trial of MR-guided delivery of AAV2-AADC for the treatment of AADC.
Guardado en:
Autores principales: | Toni S. Pearson, Nalin Gupta, Waldy San Sebastian, Jill Imamura-Ching, Amy Viehoever, Ana Grijalvo-Perez, Alex J. Fay, Neha Seth, Shannon M. Lundy, Youngho Seo, Miguel Pampaloni, Keith Hyland, Erin Smith, Gardenia de Oliveira Barbosa, Jill C. Heathcock, Amy Minnema, Russell Lonser, J. Bradley Elder, Jeffrey Leonard, Paul Larson, Krystof S. Bankiewicz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77c5fbe7e4b84dc5bdd76784b47254d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: Anouke van Rumund, et al.
Publicado: (2021) -
Spatial frequency sensitivity in macaque midbrain
por: Chih-Yang Chen, et al.
Publicado: (2018) -
Visualizing the enzyme mechanism of mevalonate diphosphate decarboxylase
por: Chun-Liang Chen, et al.
Publicado: (2020) -
Chemical modulation of the defensive behavior in the midbrain tectum
por: Brandão, M. L.; Anseloni, V. Z.; Pandóssio, J. E.; Araújo, J.; Castilho, V. M.
Publicado: (1999) -
Pyrazinamide triggers degradation of its target aspartate decarboxylase
por: Pooja Gopal, et al.
Publicado: (2020)